This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Google Scholar Articles by Tremblay, F. Articles by Gimeno, R. E. PubMed PubMed Citation Articles by Tremblay, F. Articles by Gimeno, R. E.

Disruption of G Protein-Coupled Receptor 39 Impairs Insulin Secretion in Vivo

Department of Metabolic Diseases (F.T., A.-M.T.R., S.W., M.P., R.E.G.), Wyeth Research, Cambridge, Massachusetts 02140; and Department of Exploratory Drug Safety (J.S., N.S.), Wyeth Research, Andover, Massachusetts 01810

Address all correspondence and requests for reprints to: Ruth E. Gimeno, Cardiovascular and Metabolic Diseases, Wyeth Research, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140. E-mail: rgimeno{at}wyeth.com.

GPR39 is a G protein-coupled receptor expressed in liver, gastrointestinal tract, adipose tissue, and pancreas. We have recently shown that young GPR39^–/– mice have normal body weight, food intake, and fasting glucose and insulin levels. In this study, we examined the role of GPR39 in aging and diet-induced obese mice. Body weight and food intake were similar in wild-type and GPR39^–/– mice as they aged from 12 to 52 wk or when fed a low-fat/high-sucrose or high-fat/high-sucrose diet. Fifty-two-week-old GPR39^–/– mice showed a trend toward decreased insulin levels after oral glucose challenge. When fed either a low-fat/high-sucrose or high-fat/high-sucrose diet, GPR39^–/– mice had increased fed glucose levels and showed decreased serum insulin levels during an oral glucose tolerance test in the face of unchanged insulin tolerance. Pancreas morphology and glucose-stimulated insulin secretion in isolated islets from wild-type and GPR39^–/– mice were comparable, suggesting that GPR39 is not required for pancreas development or ex vivo insulin secretion. Small interfering RNA-mediated knockdown of GPR39 in clonal NIT-1 β-cells revealed that GPR39 regulates the expression of insulin receptor substrate-2 and pancreatic and duodenal homeobox-1 in a cell-autonomous manner; insulin receptor substrate-2 mRNA was also significantly decreased in the pancreas of GPR39^–/– mice. Taken together, our data indicate that GPR39 is required for the increased insulin secretion in vivo under conditions of increased demand, i.e. on development of age-dependent and diet-induced insulin resistance. Thus, GPR39 agonists may have potential for the treatment of type 2 diabetes.

This article has been cited by other articles:

				B. Holst, K. L. Egerod, C. Jin, P. S. Petersen, M. V. Ostergaard, J. Hald, A. M. E. Sprinkel, J. Storling, T. Mandrup-Poulsen, J. J. Holst, et al. G Protein-Coupled Receptor 39 Deficiency Is Associated with Pancreatic Islet Dysfunction Endocrinology, June 1, 2009; 150(6): 2577 - 2585. [Abstract] [Full Text] [PDF]